Better benefits start here
Ann and Dave discuss why Prime’s model is different, how we’re strategic with our partnerships and how we leverage information to provide holistic member care.
As part of our total drug management strategy, we actively promote evidence-based use of biosimilars (and other low-cost drug options) and endorsed by our Pharmacy and Therapeutics Committee.Learn more
We take a deeply integrated, channel independent, holistic approach to designing products that manage cost and provide smarter care that’s right for each person.
We are connected where medicines play a role to unlock better, more affordable care.
Built on the strength from a unique Blue + Prime foundation, we’ve grown from a small pharmacy benefit manager (PBM) to a leading total drug management enterprise.
November 28, 2022
This quarterly pipeline wrap-up provides a review of newly approved specialty drugs, recent…
November 18, 2022
This quarterly pipeline wrap-up provides a review of newly approved traditional drugs, recent…
November 15, 2022
Mitchell Scott is Senior Director of Prime’s Special Investigations Unit (SIU) and Pharmacy…
Each Blue Cross® and/or Blue Shield® plan is an independent licensee of the Blue Cross and Blue Shield Association.